BridgeMD
New treatment option for Schistosomiasis
Official title Assessment of Infection Activity in Travelers and Migrants Diagnosed With Chronic Schistosomiasis
ClinicalTrials.gov ID: NCT06873308
What this study is testing
- What it's testing
- The primary objective of this clinical investigation is to determine the percentage of travelers and migrants diagnosed with chronic schistosomiasis according to site-specific diagnostic practice who have active infection at the time of evaluation (as assessed and classified by composite reference standards that integrate clinical, laboratory, and diagnostic features, such as microscopy, PCR (where available), POC-CCA (where available), and serum CAA results). All subjects with chronic schistosomiasis according to site-specific diagnostic practice will have a standardized baseline clinical and laboratory evaluation at the time of evaluation that will include blood sampling for hematology, schistosome serology available at each site, and schistosome PCR where available; urine sampling for microscopy, determination of hematuria as an indirect marker of morbidity for schistosomiasis, and Schistosome PCR (where available), and urine strip testing POC-CCA (where available); and stool sampling for microscopy and PCR, where available, and fecal occult blood as indirect markers of schistosomiasis morbidity.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 and older
You may be able to join if
- diagnosis of chronic schistosomiasis (\>3 months after last potential exposure) according to site-specific diagnostic practice
- signed informed consent (and assent for minors).
You likely can't join if
- age below 5 years;
- exposure to praziquantel after the last potential exposure to schistosomes
- acute infection, i.e. likely infection \<3 months before presentation
The study team makes the final eligibility decision.
Where it's taking place
- Antwerp, Belgium
- Hamburg, Germany
- Bologna, BO, Italy
- Negrar, VR, Italy
- Florence, Italy
- Rotterdam, Netherlands
- Almería, Spain
- Barcelona, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Antwerp, Belgium; Hamburg, Germany; Bologna, BO, Italy; Negrar, VR, Italy; Florence, Italy; Rotterdam, Netherlands and 2 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.